Eli Lilly Newswire

Eli Lilly Newswire

Comprehensive Real-Time News Feed for Eli Lilly.

Results 1 - 20 of 1,074 in Eli Lilly

  1. Alzheimer's Disease: Does THC Hold The Key To A Cure?Read the original story w/Photo

    10 hrs ago | Seeking Alpha

    ... with cancer. There is no prevention. There is no cure. There is no treatment, even. That's why the failure of Eli Lilly and Co.'s (NYSE: LLY ) solanezumab immunotherapy in a high-profile, highly anticipated Phase III clinical trial made so many ...

    Comment?

  2. Eli Lilly Confirms Date And Conference Call For 2017 Financial Guidance AnnouncementRead the original story w/Photo

    Yesterday | BioSpace

    /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its financial guidance for 2017 and provide updated financial guidance for 2016 on . Lilly will also conduct a conference call on that day with the investment community and media to ...

    Comment?

  3. Eli Lilly Introduces Scholars Programs For s And s Business StudentsRead the original story w/Photo

    Wednesday | BioSpace

    ... it provides students with an internship at an exceptional corporation and a scholarship reward," said About Eli Lilly and Company Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. ...

    Comment?

  4. Daiwa Securities Group Inc. Sells 1,550 Shares of Eli Lilly and Co.Read the original story w/Photo

    Wednesday | IntersportsWire

    Daiwa Securities Group Inc. decreased its position in Eli Lilly and Co. by 3.9% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission.

    Comment?

  5. Like a boss: Obama approaches transition as a CEO and mentorRead the original story w/Photo

    Wednesday Nov 30 | The Hill

    ... chairman is a sign of a healthy and forward-looking leadership team that has the company's best interest at heart. Eli Lilly earned a reputation for the well-executed succession, with no drama and a great emphasis on planning. When Dave Ricks was ...

    Comment?

  6. Eli Lilly and Co. (LLY) Forecasted to Earn FY2016 Earnings of $3.48 Per ShareRead the original story w/Photo

    Wednesday Nov 30 | IntersportsWire

    Stock analysts at Leerink Swann lowered their FY2016 EPS estimates for Eli Lilly and in a research report issued on Wednesday. Leerink Swann analyst S. Fernandez now expects that the firm will earn $3.48 per share for the year, down from their previous estimate of $3.57.

    Comment?

  7. Atlantic Securities Lowers Eli Lilly and Co. (LLY) to NeutralRead the original story w/Photo

    Wednesday Nov 30 | IntersportsWire

    LLY has been the subject of a number of other research reports. BMO Capital Markets reiterated a buy rating and issued a $94.00 price target on shares of Eli Lilly and in a research note on Monday, October 3rd.

    Comment?

  8. Donald Trump Rescues the Working Class in IndianaRead the original story w/Photo

    Tuesday Nov 29 | Mother Jones

    ... and middle class jobs in Indianapolis is not Carrier - or any other heavy manufacturing company. The top ten are Eli Lilly, Indiana University, Purdue University, St. Vincent Hospital, St. Francis Hospital, CNA Financial Group, Methodist Hospital, ...

    Comment?

  9. Is It Time To Buy Eli Lilly?Read the original story w/Photo

    Tuesday Nov 29 | Seeking Alpha

    Last week was a nightmare for anyone holding Eli Lilly & Co. . Investors that went to bed holding the stock at $75.99 woke up to the dreaded gap down, with the stock opening off 15% at $64.35 on news of a failed experimental Alzheimer's drug.

    Comment?

  10. Pfizer Inc. (PFE), Eli Lilly And Co (LLY) Impotence Drugs Price Increases Leave Patients DisgruntledRead the original story w/Photo

    Tuesday Nov 29 | Insider Monkey

    Pfizer Inc. and Eli Lilly and Co are yet again the subject of immense criticism as their practice of increasing the prices of key drugs in the impotence drug market in tandem continues to leave patients with no other options. Over the last five years, prices for Viagra and Cialis have more than doubled.

    Comment?

  11. The Difference Between Shareholders And StakeholdersRead the original story w/Photo

    Tuesday Nov 29 | Benzinga

    ... and building a sustainable relationship between company and stakeholder. The news out earlier this month of Eli Lilly and Co (NYSE: LLY ) throwing the towel on its Alzheimer's treatment candidate impacted shareholders of the company as well of those ...

    Comment?

  12. Fear of Layoffs Loom Over Eli Lilly Employees After Alzheimer's SetbackRead the original story

    Monday Nov 28 | BioSpace

    Layoffs could be coming to Indianapolis based drug-maker Eli Lilly and Company after its Alzheimer's drug failed a large-scale trial. Lilly announced last week, Solanezumab or 'sola', did not show significant slowing in cognitive decline in Alzheimer's patients with mild dementia.

    Comment?

  13. Q4 2016 EPS Estimates for Eli Lilly and Co. Cut by AnalystRead the original story w/Photo

    Tuesday Nov 29 | IntersportsWire

    Analysts at SunTrust Banks cut their Q4 2016 EPS estimates for shares of Eli Lilly and in a research report issued on Wednesday. SunTrust Banks analyst J. Boris now expects that the brokerage will post earnings of $0.94 per share for the quarter, down from their prior forecast of $1.03.

    Comment?

  14. Eli Lilly and Co. (LLY) Stock Rating Lowered by Atlantic SecuritiesRead the original story w/Photo

    Tuesday Nov 29 | Daily Political

    LLY has been the subject of several other reports. Deutsche Bank AG reaffirmed a "buy" rating on shares of Eli Lilly and in a research report on Tuesday, September 20th.

    Comment?

  15. JPMorgan Chase & Co. Analysts Give Eli Lilly and Co. (LLY) a $85.00 Price TargetRead the original story w/Photo

    Monday Nov 28 | Daily Political

    LLY has been the subject of several other reports. Deutsche Bank AG restated a buy rating on shares of Eli Lilly and in a research note on Tuesday, September 20th.

    Comment?

  16. Eli Lilly and Co. (LLY) Stake Reduced by British Columbia Investment Management CorpRead the original story w/Photo

    Monday Nov 28 | Daily Political

    British Columbia Investment Management Corp cut its stake in shares of Eli Lilly and Co. by 18.2% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission.

    Comment?

  17. Failed Alzheimer's Trial Does Not Kill Leading Theory of DiseaseRead the original story w/Photo

    Monday Nov 28 | Scientific American

    ... up amyloid proteins from the blood and cerebrospinal fluid. The proteins can go on to form plaques in the brain. Eli Lilly, the company that developed solanezumab, announced on 23 November that it would abandon the drug as a treatment for patients ...

    Comment?

  18. Eli Lilly's promising Alzheimer's drug fails in clinical trialsRead the original story w/Photo

    Wednesday Nov 23 | KION 46

    ... being seen as a disappointing setback, but not the end of hopes to fight the disease. On Wednesday, US drugmaker Eli Lilly announced that the Phase 3 clinical trial of its drug solanezumab did not progress as planned. "Patients treated with ...

    Comment?

  19. Jim Cramer -- Eli Lilly's Alzheimer Drug Failure Is a Major DisasterRead the original story w/Photo

    Monday Nov 28 | TheStreet.com

    Eli Lilly built up much false hope by being far too bullish on its now-failed Alzheimer treatment, Cramer said. Shares of Eli Lilly are down 2% Monday and down roughly 12% since its negative announcement last Wednesday regarding its failed late-stage Alzheimer treatment.

    Comment?

  20. Eli Lilly and Co. (LLY) Downgraded by BMO Capital MarketsRead the original story w/Photo

    Monday Nov 28 | Daily Political

    ... $91.00. Several other research firms also recently commented on LLY. Argus boosted their target price on shares of Eli Lilly and from $90.00 to $95.00 and gave the stock a buy rating in a research report on Tuesday, August 2nd. Zacks Investment ...

    Comment?